loading
Precedente Chiudi:
$14.82
Aprire:
$14.82
Volume 24 ore:
2.09M
Relative Volume:
1.27
Capitalizzazione di mercato:
$1.28B
Reddito:
$-249.00K
Utile/perdita netta:
$-187.60M
Rapporto P/E:
-5.724
EPS:
-2.5
Flusso di cassa netto:
$-201.88M
1 W Prestazione:
-5.67%
1M Prestazione:
+6.16%
6M Prestazione:
+182.81%
1 anno Prestazione:
+188.51%
Intervallo 1D:
Value
$13.88
$15.07
Intervallo di 1 settimana:
Value
$13.88
$16.96
Portata 52W:
Value
$2.865
$16.96

Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile

Name
Nome
Amylyx Pharmaceuticals Inc
Name
Telefono
617-683-0917
Name
Indirizzo
43 THORNDIKE STREET, CAMBRIDGE
Name
Dipendente
123
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-04
Name
Ultimi documenti SEC
Name
AMLX's Discussions on Twitter

Confronta AMLX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AMLX
Amylyx Pharmaceuticals Inc
14.31 1.63B -249.00K -187.60M -201.88M -2.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Ripresa Goldman Buy
2025-06-24 Iniziato Guggenheim Buy
2025-06-17 Iniziato Citigroup Buy
2025-05-30 Iniziato TD Cowen Buy
2025-04-07 Aggiornamento Mizuho Neutral → Outperform
2024-11-18 Aggiornamento Robert W. Baird Neutral → Outperform
2024-10-23 Aggiornamento BofA Securities Neutral → Buy
2024-03-18 Downgrade Mizuho Buy → Neutral
2024-03-11 Downgrade Leerink Partners Outperform → Market Perform
2024-03-11 Downgrade Robert W. Baird Outperform → Neutral
2024-03-08 Downgrade Evercore ISI Outperform → In-line
2024-03-08 Downgrade Goldman Buy → Neutral
2024-01-03 Iniziato Robert W. Baird Outperform
2023-12-12 Iniziato Deutsche Bank Buy
2023-07-24 Aggiornamento Goldman Neutral → Buy
2023-03-31 Iniziato Mizuho Buy
2023-01-05 Iniziato BofA Securities Buy
2022-05-25 Iniziato Citigroup Buy
2022-04-01 Downgrade Goldman Buy → Neutral
Mostra tutto

Amylyx Pharmaceuticals Inc Borsa (AMLX) Ultime notizie

pulisher
02:58 AM

Trend analysis for Amylyx Pharmaceuticals Inc. this weekJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com

02:58 AM
pulisher
Oct 23, 2025

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); ... - Bluefield Daily Telegraph

Oct 23, 2025
pulisher
Oct 23, 2025

Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm - Eastern Progress

Oct 23, 2025
pulisher
Oct 23, 2025

Using flow based indicators on Amylyx Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

What’s the recovery path for long term holders of Amylyx Pharmaceuticals Inc.July 2025 Setups & Expert Curated Trade Setups - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Will Amylyx Pharmaceuticals Inc. price bounce be sustainableTrade Analysis Summary & Community Verified Swing Trade Signals - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Amylyx gets FDA fast track status for ALS treatment - MSN

Oct 22, 2025
pulisher
Oct 22, 2025

Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. t - GuruFocus

Oct 22, 2025
pulisher
Oct 22, 2025

Measuring Amylyx Pharmaceuticals Inc.’s beta against major indices2025 Price Targets & Technical Pattern Based Buy Signals - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Will Amylyx Pharmaceuticals Inc. continue its uptrendTrade Exit Summary & Technical Pattern Based Buy Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Tools to monitor Amylyx Pharmaceuticals Inc. recovery probabilityJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Using economic indicators to assess Amylyx Pharmaceuticals Inc. potential2025 Volume Leaders & Daily Price Action Insights - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 22:38:43 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Important Notice to Long-Term Shareholders of Amylyx - GlobeNewswire

Oct 20, 2025
pulisher
Oct 20, 2025

Will Amylyx Pharmaceuticals Inc. stock deliver better than expected guidanceWeekly Trade Analysis & Consistent Income Trade Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why Amylyx Pharmaceuticals Inc. stock attracts global investorsWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

How the Class Action Investigation Into Relyvrio Disclosures at Amylyx Pharmaceuticals (AMLX) Has Changed Its Investment Story - Sahm

Oct 19, 2025
pulisher
Oct 19, 2025

How Amylyx Pharmaceuticals Inc. stock benefits from global expansionRecession Risk & Advanced Technical Signal Analysis - nchmf.gov.vn

Oct 19, 2025
pulisher
Oct 18, 2025

Is Amylyx Pharmaceuticals Inc. stock attractive for long term wealth buildingPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

How supply chain issues affect Amylyx Pharmaceuticals Inc. stockPortfolio Return Report & Scalable Portfolio Growth Methods - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Growth Value: Why Amylyx Pharmaceuticals Inc. stock attracts global investorsBull Run & High Yield Equity Trading Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonInsider Buying & Expert Approved Momentum Ideas - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Aug Swings: Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Summary & Low Risk Profit Maximizing Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Volatility Watch: Will Amylyx Pharmaceuticals Inc. stock beat EPS estimates2025 Technical Overview & Free Real-Time Market Sentiment Alerts - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Amylyx Pharmaceuticals (AMLX): Assessing Valuation After Class Action Probe Challenges Relyvrio Demand Claims - Sahm

Oct 17, 2025
pulisher
Oct 17, 2025

Will Amylyx Pharmaceuticals Inc. stock beat EPS estimatesShort Setup & Weekly Top Performers Watchlists - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Exit Recap: Is Amylyx Pharmaceuticals Inc. stock affected by interest rate hikesGold Moves & Expert Curated Trade Setups - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Oklahoma City NewsThe Oklahoman - FinancialContent

Oct 17, 2025
pulisher
Oct 17, 2025

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Assessing the 15.36% Upside Potential and Strong Analyst Ratings - DirectorsTalk Interviews

Oct 17, 2025
pulisher
Oct 16, 2025

Is AMLX Stock a Solid Choice Right Now? - sharewise.com

Oct 16, 2025
pulisher
Oct 16, 2025

AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire

Oct 16, 2025
pulisher
Oct 16, 2025

About Us - FinancialContent

Oct 16, 2025
pulisher
Oct 16, 2025

Baird Maintains Amylyx Pharmaceuticals (AMLX) Outperform Recommendation - Nasdaq

Oct 16, 2025
pulisher
Oct 15, 2025

How institutional ownership impacts Amylyx Pharmaceuticals Inc. stockWeekly Trend Recap & Technical Pattern Based Signals - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Amylyx Pharmaceuticals prices $175M public offering - MSN

Oct 14, 2025

Amylyx Pharmaceuticals Inc Azioni (AMLX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$36.85
price up icon 0.03%
$89.31
price up icon 1.42%
$29.87
price down icon 0.17%
$104.75
price down icon 1.39%
$160.12
price down icon 0.17%
biotechnology ONC
$310.03
price down icon 1.12%
Capitalizzazione:     |  Volume (24 ore):